Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives $13.17 Average Target Price from Analysts
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy […]
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy […]
